About Netupitant,Palonosetron Hydrochloride
            
            Class:|Antiemetic combination (NK1 receptor antagonist and 5-HT3 receptor antagonist).  
Use:|Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.  
Adult dose:|One capsule (Netupitant 300 mg/Palonosetron 0.5 mg) orally approximately 1 hour prior to the start of chemotherapy.  
Pediatric dose:|Safety and efficacy not established in pediatric patients.  
Side effects:|Headache, fatigue, dyspepsia, constipation, and erythema.  
Cont
         
        
            
                
                
                    
                        Drug Class
                    
                    |Antiemetic combination (NK1 receptor antagonist and 5-HT3 receptor antagonist).
                 
                
                
                    
                        Uses & Indications
                    
                    |Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.
                 
                
                
                    
                        Storage Requirements
                    
                    |Store at
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Juniper Biologics Pty Ltd [North Sydney,Australia], Australia
                    
                    
                    Package Size
                    1's Blister
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 437.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        |One capsule (Netupitant 300 mg/Palonosetron 0.5 mg) orally approximately 1 hour prior to the start of chemotherapy.
                    
                    
                        Pediatric Dose
                    
                    
                        |Safety and efficacy not established in pediatric patients.
                    
                 
                
                
                    
                        Side Effects
                    
                    |Headache, fatigue, dyspepsia, constipation, and erythema.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            |Hypersensitivity to netupitant, palonosetron, or any component of the formulation.
         
        
        
            
                Important Warnings
            
            Not available
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.